文献速递青光眼

更新的就必然更好吗?小梁切除术问世以来青光眼切开手术百年演变

Is Newer Necessarily Better? The Evolution of Incisional Glaucoma Surgery Over the Last 100 Years.
PubMed 文献 · Am J Ophthalmol · 2018-04-13

本文为视角性文献综述,回顾100年来青光眼切开手术的关键里程碑并评估其风险与获益。结论指出,50多年前描述的小梁切除术仍是药物及激光治疗无效、需将眼压降至十几mmHg患者的最优选择;新技术需在良好设计的临床试验中与小梁切除术这一金标准比较安全性和有效性。

要点

  • 小梁切除术仍是药物和激光治疗无效、需将眼压降至十几mmHg患者的最优选择。
  • 小梁切除术的效果有赖于合适的患者选择、精细的手术技术和密集的术后随访。
  • 新的青光眼手术需在良好设计的临床试验中与小梁切除术比较安全性和有效性。

核心结论

  • 小梁切除术仍是药物及激光治疗无效、需将眼压降至十几mmHg患者降低眼压的最优选择。
  • 合适的患者选择、精细的手术技术和密集的随访可优化小梁切除术的效果。
  • 更新的手术需在良好设计的临床试验中仔细研究,以确定其相对金标准的安全性和有效性水平。
  • 药物递送和微创青光眼手术的进步可能最终为青光眼患者带来最佳结局。

研究设计与样本

  • 本文为视角性文献综述,对青光眼切开手术演变中的关键里程碑进行回顾性评估。
  • 评估内容为这些手术的风险与获益,获益定义为有效降低眼压和保护视功能,风险定义为患者的安全性和并发症,同时考虑生活质量。

主要发现

  • 过去100年虽取得进展,但50多年前描述的小梁切除术仍是药物及激光治疗无效、需将眼压降至十几mmHg患者的最优选择。
  • 青光眼切开手术的获益定义为有效降低眼压和保护视功能,风险定义为患者的安全性和并发症。

临床怎么用

  • 作者认为,合适的患者选择、精细的手术技术和密集的患者随访可优化小梁切除术的效果。
  • 作者认为,更新的手术需在良好设计的临床试验中仔细研究,以确定其相对小梁切除术这一金标准的安全性和有效性水平。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the progress made in glaucoma incisional surgery and determine if there has been sufficient progress to meet the needs of glaucoma patients. DESIGN: Perspective (literature review). METHODS: This is a retrospective assessment of key milestones in the evolution of glaucoma incisional surgery and an evaluation of the risks and the benefits of these procedures. Benefits are defined as effective reduction in intraocular pressure (IOP) and protecting visual function, while risks are defined as safety and complications for our patients. Quality of life is also considered. RESULTS: Although advances have been made in the last 100 years, the trabeculectomy, a procedure that was described more than 50 years ago, remains the optimal choice for reducing IOP among those patients who require pressures in the teens, who do not respond to medications and prior laser therapy. CONCLUSIONS: Appropriate patient selection, careful attention to surgical technique, and intensive follow-up of patients will optimize the results of a trabeculectomy. Newer procedures must be carefully studied in well-designed clinical trials to determine comparative levels of safety and efficacy to this gold standard. Advances in drug delivery and minimally invasive glaucoma surgery may ultimately produce the best outcome for glaucoma patients in the future.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Higginbotham EJ, Alexis D. Is Newer Necessarily Better? The Evolution of Incisional Glaucoma Surgery Over the Last 100 Years. Am J Ophthalmol. 2018. PMID: 29655641. doi:10.1016/j.ajo.2018.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。